Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin

por Schwartz, Stanley S
Publicado 2010

Optimizing glycemic control and minimizing the risk of hypoglycemia in patients with type 2 diabetes

por Schwartz, Stanley S
Publicado 2013

MON-618 A Framework for Understanding and Managing ‘The Diabetes Syndrome’: A Unified Pathophysiologic Approaching the Context of the Beta-Cell Classification of Diabetes

por Schwartz, Stanley S
Publicado en J Endocr Soc (2020)

Practice of Hypnosis in Anesthesiology

por Schwartz, Stanley N.
Publicado 1965

Applied Hypnosis and Positive Suggestion

por Schwartz, Stanley N.
Publicado 1966

Sodium–glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin–metformin

por Schwartz, Stanley S, Katz, Arie
Publicado en Diabetes Metab Syndr Obes (2016)

Glycemic Control and Weight Reduction Without Causing Hypoglycemia: The Case for Continued Safe Aggressive Care of Patients With Type 2 Diabetes Mellitus and Avoidance of Therapeut...

por Schwartz, Stanley S., Kohl, Benjamin A.
Publicado 2010

Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies

por Schwartz, Stanley, Kohl, Benjamin A
Publicado 2010

Diabetic Retinopathy–An Underdiagnosed and Undertreated Inflammatory, Neuro-Vascular Complication of Diabetes

por Sinclair, Stephen H., Schwartz, Stanley S.
Publicado en Front Endocrinol (Lausanne) (2019)

In Vitro and Animal Models of Human Immunodeficiency Virus Infection of the Central Nervous System

por Nesbit, Chadd E., Schwartz, Stanley A.
Publicado 2002

Is Incretin-Based Therapy Ready for the Care of Hospitalized Patients With Type 2 Diabetes?: The time has come for GLP-1 receptor agonists!

por Schwartz, Stanley, DeFronzo, Ralph A.
Publicado 2013

Mucosal immunity: The immunology of breast milk

por Slade, Herbert B., Schwartz, Stanley A.
Publicado en J Allergy Clin Immunol (1987)

Reversal of Human Immunodeficiency Virus Type 1 Protein-Induced Inhibition of Natural Killer Cell Activity by Alpha Interferon and Interleukin-2

por Nair, Madhavan P. N., Schwartz, Stanley A.
Publicado 2000

Current Concepts in Human Immunodeficiency Virus Infection and AIDS

por Schwartz, Stanley A., Nair, Madhavan P. N.
Publicado 1999

An evidence-based practice-oriented review focusing on canagliflozin in the management of type 2 diabetes

por Messana, Joseph A, Schwartz, Stanley S, Townsend, Raymond R
Publicado en Vasc Health Risk Manag (2017)

The Diabetes Syndrome – A Collection of Conditions with Common, Interrelated Pathophysiologic Mechanisms

por Rachfal, Amy W, Grant, Struan F A, Schwartz, Stanley S
Publicado en Int J Gen Med (2021)

Immunological assays for chemokine detection in in-vitro culture of CNS cells

por Mahajan, Supriya D., Schwartz, Stanley A., Nair, Madhavan P.N.
Publicado 2003

Diabetes and Psoriasis: Different Sides of the Same Prism

por Abramczyk, Rachel, Queller, Jenna N, Rachfal, Amy W, Schwartz, Stanley S
Publicado en Diabetes Metab Syndr Obes (2020)

Intranasal Interferon-α2b for Seasonal Prophylaxis of Respiratory Infection

por Monto, Arnold S., Shope, Thomas C., Schwartz, Stanley A., Albrecht, Janice K.
Publicado en J Infect Dis (1986)

PIRT: Patient Intake and Recommendations Tool

por Szczepkowski, Michael A., Weiland, Monica Z., Schwartz, Stanley, Zachary, Wayne, Daly, Mary
Publicado 1999